首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2016年 10期 肝病免疫和自身免疫性肝病 => 其他 =>蒙药清肝九味散治疗酒..
蒙药清肝九味散治疗酒精性肝炎的效果观察
Clinical effect of Mongolian drug Qinggan Jiuwei powder in treatment of alcoholic hepatitis
文章发布日期:2016年09月07日  来源:  作者:戈宏焱,赵百岁,张仕华,等  点击次数:1772次  下载次数:265次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的观察蒙药清肝九味散对酒精性肝炎患者的治疗作用。方法收集内蒙古民族大学附属医院2014年5月-2016年4月收治的酒精性肝炎患者63例,随机分为试验组(32例)和对照组(31例)。试验组给予蒙药清肝九味散治疗;对照组31例给予还原型谷胱甘肽片治疗。2组患者均治疗4周并在此期间均严格戒酒、卧床休息。计量资料组间比较采用t检验。结果对照组患者肝功能指标(ALT、AST、GGT)治疗后与治疗前比较均有明显改善[(38.7±13.3)U/L vs(77.5±16.7)U/L)、(43.8±218)U/L vs(176.6±40.1)U/L、(63.8±21.7)U/L vs(302.9±73.3)U/L,t值分别为10.21、16.90、17.40,P值均<0.01];试验组患者治疗后与治疗前比较亦有明显改善[(37.6±14.6) U/L vs(78.1±17.5)U/L、(39.6±15.3) U/L vs(180.3±44.3)U/L、(59.9±23.8) U/L vs(304.7±66.5)U/L,t值分别为10.10、16.40、19.60,P值均<0.01]。对照组患者血清中肝纤维化指标(透明质酸、Ⅲ型前胶原、层黏连蛋白、Ⅳ型胶原)治疗后均较治疗前明显改善[(122.1±36.2)ng/ml vs(369.2±139.8)ng/ml、(118.6±43.8)ng/ml vs(185.9±92.7)ng/ml、(137.2±49.9)ng/ml vs(166.1±50.4)ng/ml、(128.7±48.3)ng/ml vs(155.1±44.5)ng/ml,t值分别为9.52、3.66、2.24、2.27,P值均<005];试验组患者治疗后与治疗前比较亦有明显改善[(101.1±27.9)ng/ml vs(367.4±149.7)ng/ml、(91.6±48.4)ng/ml vs(188.3±100.5)ng/ml、(94.8±34.6)ng/ml vs(167.6±48.7)ng/ml、(92.7±30.3)ng/ml vs(161.3±62.2)ng/ml,t值分别为9.88、4.95、5.61、6.87,P值均<001]。2组间治疗后肝纤维化指标比较差异均有统计学意义(t值分别为2.53、2.31、3.56、3.90,P值均<0.05)。结论蒙药清肝九味散可以改善酒精性肝炎患者的肝功能,降低肝纤维化指标。
【Abstract】:ObjectiveTo investigate the clinical effect of Mongolian drug Qinggan Jiuwei powder in the treatment of patients with alcoholic hepatitis. MethodsA total of 63 patients with alcoholic hepatitis who were admitted to Affiliated Hospital of Inner Mongolia University for The Nationalities from May 2014 to April 2016 were enrolled. The 32 patients in the trial group were given Mongolian drug Qinggan Jiuwei powder, and the 31 patients in the control group were given reduced glutathione tablets. The course of treatment was 4 weeks for both groups, and the patients were asked to quit drinking, stay in bed, and have a rest. The t-test was used for the comparison of continuous data between groups. ResultsAfter treatment, the control group showed significant improvements in the liver function parameters alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transpeptidase (GGT) (ALT: 38.7±13.3 U/L vs 77.5±16.7 U/L, t=10.21, P<0.01; AST: 43.8±21.8 U/L vs 176.6±40.1 U/L, t=16.90, P<0.01; GGT: 63.8±21.7 U/L vs 302.9±73.3 U/L, t=17.40, P<0.01); the trial group also showed significant improvements in these parameters (ALT: 37.6±14.6 U/L vs 781±17.5 U/L, t=10.10, P<0.01; AST: 39.6±15.3 U/L vs 180.3±44.3 U/L, t=16.40, P<0.01; GGT: 59.9±23.8 U/L vs 304.7±66.5 U/L, t=19.60, P<0.01). After treatment, the control group showed significant improvements in the serum liver fibrosis parameters hyaluronic acid, precollagen type Ⅲ, laminin, and collagen type Ⅳ(hyaluronic acid: 122.1±36.2 ng/ml vs 369.2±139.8 ng/ml, t=9.52, P<0.05; precollagen type Ⅲ: 118.6±43.8 ng/ml vs 185.9±92.7 ng/ml, t=3.66, P<0.05; laminin: 137.2±499 ng/ml vs 166.1±50.4 ng/ml, t=2.24, P<0.05; collagen type Ⅳ: 128.7±48.3 ng/ml vs 155.1±44.5 ng/ml, t=2.27, P<005); the trial group also showed significant improvements in these parameters (hyaluronic acid: 101.1±27.9 ng/ml vs 367.4±149.7 ng/ml, t=9.88, P<0.01; precollagen type Ⅲ: 91.6±48.4 ng/ml vs 188.3±100.5 ng/ml, t=4.95, P<0.01; laminin: 94.8±34.6 ng/ml vs 167.6±48.7 ng/ml, t=5.61, P<0.01; collagen type Ⅳ: 92.7±30.3 ng/ml vs 161.3±62.2 ng/ml, t=6.87, P<0.01). There were significant differences in the liver function parameters after treatment between the two groups (t=2.53, 2.31, 3.56, and 3.90, all P<0.05). ConclusionThe Mongolian drug Qinggan Jiuwei powder can improve liver function and reduce liver fibrosis parameters in patients with alcoholic hepatitis.
【关键字】:肝炎, 酒精性; 蒙药; 治疗结果
【Key words】:hepatitis, alcoholic; mongolian drugs; treatment outcome
【引证本文】:戈宏焱, 赵百岁, 张仕华, 等. 蒙药清肝九味散治疗酒精性肝炎的效果观察[J]. 临床肝胆病杂志, 2016, 32(10): 1947-1950.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号